221 related articles for article (PubMed ID: 24394867)
1. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
2. Effect of speech therapy and pharmacological treatment in prosody of parkinsonians.
Azevedo LL; Souza IS; Oliveira PM; Cardoso F
Arq Neuropsiquiatr; 2015 Jan; 73(1):30-5. PubMed ID: 25608124
[TBL] [Abstract][Full Text] [Related]
3. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
4. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
[TBL] [Abstract][Full Text] [Related]
5. Prosodic expression and levodopa in Parkinson's disease.
Behlau M
Arq Neuropsiquiatr; 2013 Nov; 71(11):831-2. PubMed ID: 24394865
[No Abstract] [Full Text] [Related]
6. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
Skodda S; Grönheit W; Schlegel U
J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
[TBL] [Abstract][Full Text] [Related]
7. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
8. [Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
Azevedo LL; Cardoso F; Reis C
Arq Neuropsiquiatr; 2003 Dec; 61(4):995-8. PubMed ID: 14762605
[TBL] [Abstract][Full Text] [Related]
9. Impact of Parkinson's disease and levodopa on resting state functional connectivity related to speech prosody control.
Elfmarková N; Gajdoš M; Mračková M; Mekyska J; Mikl M; Rektorová I
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S52-5. PubMed ID: 26363673
[TBL] [Abstract][Full Text] [Related]
10. Acoustic investigation of stress patterns in Parkinson's disease.
Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
12. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
13. Glottographic measures before and after levodopa treatment in Parkinson's disease.
Jiang J; Lin E; Wang J; Hanson DG
Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
[TBL] [Abstract][Full Text] [Related]
14. Pitch variability in patients with Parkinson's disease: effects of deep brain stimulation of caudal zona incerta and subthalamic nucleus.
Karlsson F; Olofsson K; Blomstedt P; Linder J; van Doorn J
J Speech Lang Hear Res; 2013 Feb; 56(1):150-8. PubMed ID: 23165974
[TBL] [Abstract][Full Text] [Related]
15. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
[TBL] [Abstract][Full Text] [Related]
16. Emotional speech in Parkinson's disease.
Möbes J; Joppich G; Stiebritz F; Dengler R; Schröder C
Mov Disord; 2008 Apr; 23(6):824-9. PubMed ID: 18307245
[TBL] [Abstract][Full Text] [Related]
17. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems.
Plowman-Prine EK; Okun MS; Sapienza CM; Shrivastav R; Fernandez HH; Foote KD; Ellis C; Rodriguez AD; Burkhead LM; Rosenbek JC
NeuroRehabilitation; 2009; 24(2):131-44. PubMed ID: 19339752
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson's disease.
Sriranjini SJ; Ganesan M; Datta K; Pal PK; Sathyaprabha TN
Neurol India; 2011; 59(5):659-63. PubMed ID: 22019646
[TBL] [Abstract][Full Text] [Related]
19. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
[TBL] [Abstract][Full Text] [Related]
20. The effect of levodopa on vocal function in Parkinson's disease.
Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
